Purpose: The aim of this review is to summarize the main applications of mesothelin-targeting agents in the diagnosis of different types of cancers with a brief mention of nuclear magnetic resonance. Methods: The articles taken into account were selected from PubMed, Scopus, and Web of Sciences, including research articles and abstracts that deal with radioimmunotherapy and new tracers for nuclear medicine and radiodiagnosis. Articles that are not in English have been excluded. Results: Mesothelin-targeting agents were the subject of the selected articles in which tracers as 64Cu-DOTA-11-25mAb anti MSLN, 111In-MORAb-009-CHX-A″, 89Zr-MMOT0530A, 111In-amatuximab, 99mTc-A1, 89Zr-AMA, 89Zr-amatuximab, 64Cu-amatuximab, 89Zr-labeled MMOT0530A and 89Zr-B3 found application in detection of malignancies that overexpressed mesothelin. Only one article approached magnetic resonance imaging (MRI) diagnosis using superparamagnetic iron oxide nanoparticles linked to anti-mesothelin antibodies. The tracers proved to be highly sensitive in detecting mesothelin positive cells. 89Zr-labeled MMOT0530A could also be used to predict the suitability of patients to radioimmunotherapy. Conclusions: Radiolabeled anti-mesothelin antibodies could be crucial as a treatment tool and for predicting the eligibility and the response of the patient to radioimmunotherapy through the study of the expression grade of mesothelin. They can be a relevant tool for pancreatic adenocarcinoma, lung cancer, human epidermoid carcinoma, ovarian cancer, malignant mesothelioma in which mesothelin is widely expressed.
New insight and future perspective of mesothelin-targeted agents in nuclear medicine / Conte, M.; Frantellizzi, V.; Matto, A.; De Vincentis, G.. - In: CLINICAL AND TRANSLATIONAL IMAGING. - ISSN 2281-5872. - 8:4(2020), pp. 265-278.
|Titolo:||New insight and future perspective of mesothelin-targeted agents in nuclear medicine|
CONTE, MIRIAM (Primo)
FRANTELLIZZI, VIVIANA (Secondo) (Corresponding author)
MATTO, ANTONIO (Penultimo)
DE VINCENTIS, Giuseppe (Ultimo)
|Data di pubblicazione:||2020|
|Citazione:||New insight and future perspective of mesothelin-targeted agents in nuclear medicine / Conte, M.; Frantellizzi, V.; Matto, A.; De Vincentis, G.. - In: CLINICAL AND TRANSLATIONAL IMAGING. - ISSN 2281-5872. - 8:4(2020), pp. 265-278.|
|Appartiene alla tipologia:||01g Articolo di rassegna (Review)|